LNCaP公司
化学
锌
前列腺癌
癌细胞
癌症
纳米颗粒
癌症研究
MTT法
细胞毒性
细胞培养
克隆(Java方法)
体外
细胞生长
细胞
癌细胞系
生物化学
生长抑制
分子生物学
生物物理学
药品
车站3
前列腺
抗癌药
作者
Zehui Rao,Zhangjie Jiang,Chengyu Zou,Yida Zhang
摘要
ABSTRACT Here, we show how Boswellia thurifera extract may be used to bio‐inspiredly synthesize zinc nanoparticles. B. thurifera was employed as an environmentally friendly medium that served as both an in situ stabilizer and a green reductant for the produced zinc nanoparticles. The intrinsic structural characteristics of the as‐synthesized Zn NPs were studied by FE‐SEM, EDX, XRD, and UV–Vis. Prostate cancer cell lines were used to evaluate the biogenic Zn NPs' antiprostate cancer capabilities. The MTT experiment showed that the Zn NPs could strongly inhibit the proliferation of LNCaP clone FGC‐Luc2 cancer cells. In contrast to their corresponding control, Zn NPs prevent colony development. More importantly, the cells molecular pathway analysis treated with zinc nanoparticles showed that the extract increases the expression of p53 while suppressing the expression of STAT3 in cells. This suggests that STAT3 and p53 are the primary players responsible for the biological events that the extract triggers in human prostate cancer cells. Our data suggest that zinc nanoparticles might be a very promising anticancer drug against human prostate cancer cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI